A microbiome signal in severe long COVID
People with very severe long COVID showed distinct differences in the microorganisms found in their mouths and lungs in a study of more than 700 people, according to research published in the European Respiratory Journal.
The research does not establish that microbial changes cause long COVID. But it links differences in the lung microbiome with respiratory symptoms and with the cognitive and digestive problems reported by some people with the condition. The findings offer another possible route for investigating why recovery varies so widely after COVID-19.
Long COVID can affect multiple organs and its causes remain unknown. That makes the microbiome—a community of bacteria and other microbes living in and on the body—a plausible area to investigate. Previous research had pointed to changes in the gut microbiome in people with long COVID. This study examined the mouth and lungs, a relevant focus because COVID-19 is a respiratory disease.
How the study was conducted
The work was part of PHOSP-COVID and included 771 people treated for COVID-19 at one of 38 hospitals in the United Kingdom between February 2020 and March 2021. All participants had been hospitalized during their acute illness.
Researchers grouped participants by the severity of symptoms five months after hospital discharge. The categories were very severe, severe, moderate and mild. The very severe group had serious physical, mental and cognitive impairments. The severe group had serious mental and physical impairments without cognitive problems. The moderate group was characterized mainly by cognitive difficulties, while the mild group had few symptoms and good recovery.
Six months after discharge, researchers collected saliva samples and sputum samples. They then used DNA sequencing to identify the microbes present in samples from the mouth and lungs. The analysis considered both the range of microbial communities and their quantities, and compared those measurements with participants’ symptoms.
What the researchers found
The analysis found clear differences in people with very severe long COVID. In particular, the study reported differences in the lung microbiome in association with respiratory symptoms as well as cognitive and digestive problems linked with long COVID.
The study’s design is important for interpreting the result. Researchers compared microbial patterns across groups defined by their recovery status after hospitalization, rather than presenting microbiome differences as a standalone diagnostic test. The results show an association between long-COVID severity and microbial composition; they do not, on their own, show whether microbes drive symptoms, whether symptoms alter microbial communities, or whether another factor affects both.
That distinction is especially important in a complex condition. Participants had experienced COVID-19 severe enough to require hospital treatment, and the samples were collected months after their discharge. Long COVID itself encompasses physical, mental, cognitive, respiratory and digestive effects, which may not have a single biological explanation.
Why lungs and mouths matter
The mouth and lungs are connected environments, but they are not interchangeable. Saliva can provide a view of the oral microbiome, while sputum offers information about microbes in the respiratory tract. Examining both allowed the researchers to look beyond the gut, where much earlier microbiome attention has been concentrated.
The team’s reasoning is direct: if long COVID follows a disease that primarily affects the lungs, the lung microbiome is a logical place to examine. The study suggests that respiratory microbial differences may be connected to a broader set of symptoms, not solely breathing problems.
This does not mean a simple microbiome treatment is ready for use. The source report says the findings may help explain why some people develop long COVID and could point toward new treatment approaches, but it does not identify a specific therapy or recommend changes to clinical care. The result is best understood as an evidence-based lead for further study.
Implications for long-COVID research
One of the main challenges in long-COVID research is separating signals that accompany the condition from mechanisms that actively contribute to it. The new work provides a large, multi-hospital cohort and a defined sampling approach, giving researchers a basis for more targeted follow-up studies.
Future research will need to test whether these microbial patterns appear in other long-COVID populations, including people whose initial infections did not require hospitalization. It will also need to determine how microbiome differences change over time and whether they are linked to prior treatments, immune changes, diet, respiratory health or other factors.
For now, the study adds to evidence that long COVID has measurable biological associations across body systems. By connecting the lung and mouth microbiomes with symptom severity in a well-characterized cohort, it gives scientists another set of questions to pursue in a condition that continues to affect millions of people worldwide.
This article is based on reporting by Medical Xpress. Read the original article.
Originally published on medicalxpress.com
